Open AccessUse of anti-epileptic drugs in a tertiary care hospital of Eastern India with emphasis on epilepsy due to neurocysticercosis
Author(s) -
Abheek Sil,
Krishnapada Das,
Nilay Kanti Das,
Dibyendu Chakraborty,
Goutameswar Mazumdar,
Santanu Kumar Tripathi
Publication year - 2012
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.91882
Subject(s) - neurocysticercosis , clobazam , medicine , epilepsy , phenytoin , carbamazepine , pediatrics , outpatient clinic , albendazole , neurology , cysticercosis , anesthesia , surgery , psychiatry , pathology
Epilepsy is a chronic disease and neurocysticercosis is an important cause of secondary seizures. Its therapy is modified by a number of parameters and thus the pattern of anti-epileptic drugs used varies in different clinical settings. It was our objective to evaluate clinico-demographic and treatment profile of epilepsy patients attending neurology outpatient department, efficacy and side-effect profile of anti-epileptic drugs with special emphasis on epilepsy resulting from neurocysticercosis.